Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: Decreased susceptibility to 6 fluoroquinolones

Diagnostic Microbiology and Infectious Disease

Volumn 52, Issue 3, 2005, Pages 261-264

  Rodriguez Avial, Iciar ^a   Rodriguez Avial, Carmen ^a   López, Olga ^a   Picazo, Juan J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Fluoroquinolones; Nalidixic; Salmonella

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONFERENCE PAPER; DRUG SENSITIVITY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REDUCTION; SALMONELLA; SEROTYPE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; SALMONELLA; SALMONELLA INFECTIONS;

EID: 23644462702     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2005.02.013     Document Type: Conference Paper

References (18)

1. F. Albayrak, F. Cocka, B. Erdem, and A.D. Aysev Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility Int. J. Antimicrob. Chemother. 23 2004 332 336
2. M.O. Asperilla, R.A. Smego Jr., and L.K. Scott Quinolone antibiotics in the treatment of Salmonella infections Rev. Infect. Dis. 12 1990 873 889
3. C.A. Bopp, F.W. Brenner, P.I. Fields, J.G. Wells, and N.A. Strockbine Escherichia, Shigella, and Salmonella P.R. Murray E.J. Baron J.H. Jorgensen M.A. Pfaller R.H. Yolken Manual of clinical microbiology 2003 ASM Press Washington, DC 654 671
4. F.W. Brenner, R.G. Villar, F.J. Angulo, R. Tauxe, and B. Swaminathan Salmonella nomenclature J. Clin. Microbiol. 38 2000 2465 2467
5. S. Cruchaga, A. Echeitia, A. Aladueña, J. García-Peña, N. Frias, and M.A. Usera Antimicrobial resistance in salmonellae from humans, food and animals in Spain in 1998 J. Antimicrob. Chemother. 47 2001 315 321
6. J.A. Crump, T.J. Barret, J.T. Nelson, and F.J. Angulo Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae Clin. Infect. Dis. 37 2003 75 81
7. J. Frost, A. Kelleher, and B.I. Rowe Increasing ciprofloxacin resistance in salmonellas in England and Wales 1991-1994 J. Antimicrob. Chemother. 37 1996 85 91
8. A. Hakanen, P. Kotilainen, J. Jalava, A. Siitonen, and P.I. Huovinen Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test J. Clin. Microbiol. 37 1999 3572 3577
9. A. Hakanen, A. Siitonen, P. Kotilainen, and P.I. Huovinen Increasing in fluoroquinolones resistance in Salmonella serotypes in Finland during 1995-1997 J. Antimicrob. Chemother. 43 1999 145 148
10. M.J. López de Goicoechea, M.J. Echevarria, P. Berdonces, and R. Ayarza Study of the susceptibility of non-typhi Salmonella spp. in the Galdakao hospital (1992 to 1998) Rev. Esp. Quimioter. 14 2001 51 54
11. K. Molback, P. Gerner-Smidt, and H.C. Wegener Increasing quinolone resistance in Salmonella enterica serotype Enteritidis Emerg. Infect. Dis. 8 2002 514 515
12. S.J. Olsen, R. Bishop, and F. Brenner The changing epidemiology of Salmonella: trends in serotypes isolated from humans in the United States, 1987-1997 J. Infect. Dis. 183 2001 753 761
13. L. Piddock, D. Griggs, M.C. Hall, and Y.F. Jin Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients Antimicrob. Agents Chemother. 37 1993 662 666
14. J. Ruiz, D. Castro, P. Goni, J.A. Santamaria, J.J. Borrego, and J. Villa Analysis of the mechanisms of the mechanism of quinolone resistance nalidixic acid-resistance clinical isolates of Salmonella serotype Typhimurium J. Med. Microbiol. 46 1997 623 628
15. J. Szych, A. Cieslik, J. Paciorek, and S. Kaluzewski Antibiotic resistance in Salmonella enterica subsp. enterica strains isolated in Poland from 1998 to 1999 Int. J. Antimicrob. Agents 18 2001 37 42
16. E.J. Threlfall, L.R. Ward, J.A. Skinner, H.R. Smith, and S. Lacey Ciprofloxacin-resistant Salmonella typhi and treatment failure Lancet 353 1999 1590 1591
17. E.J. Threlfall, L.R. Ward, J.A. Skinner, and A. Graham Antimicrobial drug resistance in non-typhoidal salmonellas from human in England and Wales in 1999. Decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar Microb. Drug Resist. 6 2000 319 325
18. F.J. Vasallo, P. Martín-Rabadan, I. Alcala, J.M. García-Lechuz, M. Rodríguez-Creixems, and E. Bouza Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis Clin. Infect. Dis. 26 1998 534 535